VIDEO: New study shows AD patients on dupilumab may experience less severe Covid-19 symptoms

Patients being treated with dupilumab for atopic dermatitis (AD) may experience less severe Covid-19 symptoms, according to a new study.

Recent Posts

Biologic treatment of psoriasis can raise the risk of superficial fungal infections in patients, especially with IL-17 inhibitors.